Expenses rose by 3.2% to RON321.9 million, while revenues climbed by 10% to RON342.2 million.
Romania pharma market in H1/2025 contracted by 9.5% by volumes, but expanded by 3.5% by value.
(English version by Catalina Apostoiu)
Companies
Antibiotice Reports RON15.5M Profit in H1/2026, Down 74% YOY
Romanian owned drug producer Antibiotice Iasi posted a RON15.5 million net profit in the first half of 2026, 74% below the year-earlier level.